Home › Research › Prevention and risk
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention
Boobalan Thulasinathan, Kanve Nagaraj Suvilesh, Sumanas Maram, Erik M. Grossmann, Yezaz A. Ghouri, Emma Teixeiro, Joshua Chan, Jussuf T. Kaifi et al.. Gut Microbes, 2025-04-06
Topic: Brain proteins, microglia and lab models
Plain-language summary
Cancer is a long-term illness that involves an imbalance in cellular and immune functions. It can be caused by a range of factors, including exposure to environmental carcinogens, poor diet, infections, and genetic alterations. Maintaining a healthy gut microbiome is crucial for overall health, and short-chain fatty acids (SCFAs) produced by gut microbiota play a vital role in this process. Recent research has established that alterations in the gut microbiome led to decreased production of SCFA's in lumen of the colon, which associated with changes in the intestinal epithelial barrier function, and immunity, are closely linked to colorectal cancer (CRC) development and its progression. SCFAs influence cancer progression by modifying epigenetic mechanisms such as DNA methylation, histone modifications, and non-coding RNA functions thereby affecting tumor initiation and metastasis. This suggests that restoring SCFA levels in colon through microbiota modulation could serve as an innovative strategy for CRC prevention and treatment. This review highlights the critical relationship between gut microbiota and CRC, emphasizing the potential of targeting SCFAs to enhance gut health and reduce CRC risk.
What this study adds
Evidence grade: Low
This review is about gut microbial short-chain fatty acids and colorectal cancer and contains no information on Alzheimer's disease. It reports no findings relevant to treating, curing or preventing dementia.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Thulasinathan, B., Suvilesh, K. N., Maram, S., Grossmann, E. M., Ghouri, Y. A., Teixeiro, E., et al. (2025). The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention. Gut Microbes. https://doi.org/10.1080/19490976.2025.2483780
Vancouver
Thulasinathan B, Suvilesh KN, Maram S, Grossmann EM, Ghouri YA, Teixeiro E, et al. The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention. Gut Microbes. 2025. doi:10.1080/19490976.2025.2483780. PMID: 40189834.
BibTeX
@article{thulasinathan2025-40189834,
author = {Thulasinathan, Boobalan and Suvilesh, Kanve Nagaraj and Maram, Sumanas and Grossmann, Erik M. and Ghouri, Yezaz A. and Teixeiro, Emma and Chan, Joshua and Kaifi, Jussuf T. and others},
title = {{The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention}},
journal = {Gut Microbes},
year = {2025},
doi = {10.1080/19490976.2025.2483780},
pmid = {40189834},
url = {https://doi.org/10.1080/19490976.2025.2483780}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Maintaining a healthy gut microbiome is crucial for overall health, and short-chain fatty acids (SCFAs) produced by gut microbiota play a vital role in this process.
- Recent research has established that alterations in the gut microbiome led to decreased production of SCFA's in lumen of the colon, which associated with changes in the intestinal epithelial barrier function, and immunity, are closely linked to colorectal cancer (CRC) development and its progression.
- This suggests that restoring SCFA levels in colon through microbiota modulation could serve as an innovative strategy for CRC prevention and treatment.
Why it matters
This review is about gut microbial short-chain fatty acids and colorectal cancer and contains no information on Alzheimer's disease. It reports no findings relevant to treating, curing or preventing dementia.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 51/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Gut Microbes) |
| Journal's citation record | 2 / 4 | Gut Microbes: journal h-index 170 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 80 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 26.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 5 / 6 | Cited 20.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 3 / 4 | Cited 80 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Satyanarayana Rachagani: h-index 51 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Washington University in St. Louis: institution h-index 1,962 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40189834) |
| Free to read | 2 / 2 | Free to read |
| Total | 51 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1080/19490976.2025.2483780
- PubMed: 40189834
- Original source →
- Free full text: Gut Microbes →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Prevention and risk from nearby years
Also in Prevention and risk
265 studies in the library are filed under Prevention and risk with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Prevention and risk hub.